Indian Stocks Mixed: Pharma, IT Gain as Geopolitics, Weak Rupee Bite Financials

ECONOMY
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Indian Stocks Mixed: Pharma, IT Gain as Geopolitics, Weak Rupee Bite Financials
Overview

Indian stocks saw a mixed trading day, with Nifty and Sensex edging higher thanks to gains in defensive pharma and recoveries in IT and metals. Sun Pharma surged, and TCS showed strength. Shriram Finance and Axis Bank, however, faced selling pressure. Ongoing geopolitical tensions, high oil prices, and a weaker rupee are dampening overall market sentiment and raising worries for sectors reliant on imports and financial stability. Most stocks advanced.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Pharma and IT Lead the Advance

Monday's trading saw Indian markets largely sustain their positive opening, driven by strength in specific sectors. However, the market showed a split trend, with strong performances in defensive pharmaceuticals and a modest recovery in technology and metals increasingly weighed down by persistent economic challenges. Investors balanced potential gains from individual companies against broader risks from global instability and currency swings.

Sun Pharmaceutical Industries was a top performer, surging 6.96% to ₹1,733.10. This move highlights the pharmaceutical sector's role as a defensive stock during uncertain times. The rally, supported by over 1.91 crore shares traded, showed investors favor stable, less cyclical companies. The pharma sector has a market cap of about ₹4,17,484 crore and a P/E ratio around 35.49, trading below its industry average. Tata Consultancy Services (TCS) also recovered 2.21% to ₹2,449.80. Despite recent pressure on IT stocks from cautious guidance by peers, TCS's recovery points to underlying strength. Analyst ratings generally lean 'Buy' with average price targets around ₹2,948.19. TCS, with a market cap of ₹8.67 trillion and a P/E of about 16.6, trades at a discount to peers, suggesting potential upside according to Morgan Stanley and others.

Metals Gain Traction Amidst Volatility

The metals sector also saw renewed buying interest. Adani Ports And Special Economic Zone gained 2.50% to ₹1,624.80, boosted by its market position and a P/E ratio around 29.24. JSW Steel rose 2.36% to ₹1,285.30, with a market cap of roughly ₹3,07,076 crore and a P/E of about 40.5. These gains indicate that cyclical sectors are finding some support, possibly anticipating stabilization or driven by specific demand, even though overall economic sentiment remains cautious.

Financials Under Scrutiny

In contrast, the banking and financial services sector showed a weaker trend. Shriram Finance fell the most among Nifty 50 stocks, dropping 4.08% to ₹970.00. Despite recent profit growth and strong asset under management (AUM) expansion, investor concerns linger over its P/E ratio of about 18.0, which is above the sector median. Axis Bank also faced selling pressure, declining 3.51% to ₹1,318.00, even as analysts maintained positive ratings and price targets around ₹1,600. The bank's performance was hit by slow revenue growth and a drop in profit before provisions, alongside gradually declining net interest margins.

Geopolitical Storm Clouds and Currency Weakness

Underlying these market moves are persistent economic challenges. High oil prices, with Brent crude hovering around $105–108 per barrel (and hitting $125.88 in April) due to geopolitical tensions in the Middle East and disruptions in the Strait of Hormuz, are a major inflation worry. This directly impacts India's import costs and industry expenses. Adding to these concerns, the Indian rupee has continued to weaken, trading near ₹94.22 against the US dollar. Forecasts suggest further depreciation, potentially reaching ₹95.77 by late April, which increases costs for import-reliant sectors and fuels inflation worries.

The Bear Case: Risks Ahead

Despite the day's gains in some stocks, significant risks persist. Sustained high oil prices, fueled by Middle East instability, threaten India's current account deficit and inflation goals, potentially widening the budget deficit. A weaker rupee adds to imported inflation and can hurt consumer spending. While pharma and IT might benefit from currency effects, the wider economy, especially import-heavy sectors and companies with large foreign currency debts, faces considerable challenges. The financial sector, though showing strong asset quality for some like Axis Bank, is sensitive to economic slowdowns and potential stress from rising commodity costs affecting borrowers' ability to repay. Shriram Finance's recent drop, despite positive analyst views, shows investor nervousness over valuation and economic sensitivity. Shriram Finance's management has warned about challenges from rising fuel prices and forecasts for a weak monsoon.

Outlook

Looking ahead, market mood will likely stay sensitive to developments in the Middle East and the direction of oil prices and the rupee. Analysts generally rate key IT and banking stocks positively, pointing to strong fundamentals and growth prospects. However, near-term trading will likely depend on whether the afternoon buying continues against resistance levels. Sector strengths, especially in pharmaceuticals and some metals, offer some stability, but broader market gains appear limited by ongoing geopolitical and currency worries. The Nifty faces resistance around 24,300–24,400, and the Bank Nifty faces a hurdle at 56,800–57,000.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.